SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-16-523721
Filing Date
2016-03-30
Accepted
2016-03-30 16:08:28
Documents
62
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d108245d10k.htm 10-K 638557
2 EX-23.1 d108245dex231.htm EX-23.1 1448
3 EX-31.1 d108245dex311.htm EX-31.1 8551
4 EX-32.1 d108245dex321.htm EX-32.1 3411
11 GRAPHIC g108245g0322065113777.jpg GRAPHIC 39768
  Complete submission text file 0001193125-16-523721.txt   3387603

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rxii-20151231.xml EX-101.INS 451586
6 XBRL TAXONOMY EXTENSION SCHEMA rxii-20151231.xsd EX-101.SCH 36923
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxii-20151231_cal.xml EX-101.CAL 62809
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxii-20151231_def.xml EX-101.DEF 129048
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxii-20151231_lab.xml EX-101.LAB 352583
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxii-20151231_pre.xml EX-101.PRE 252199
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36304 | Film No.: 161539674
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences